Generation and characterization of protective antibodies to Marburg virus
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Generation and characterization of protective antibodies to Marburg virus
Authors
Keywords
-
Journal
mAbs
Volume 9, Issue 4, Pages 696-703
Publisher
Informa UK Limited
Online
2017-03-13
DOI
10.1080/19420862.2017.1299848
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)
- (2017) Ana Maria Henao-Restrepo et al. LANCET
- Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014–2015 outbreak
- (2016) Tansy Edwards et al. Clinical Trials
- Molecular determinants of plaque size as an indicator of dengue virus attenuation
- (2016) Kenneth Choon Meng Goh et al. Scientific Reports
- Mechanism of Human Antibody-Mediated Neutralization of Marburg Virus
- (2015) Andrew I. Flyak et al. CELL
- Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
- (2015) Marnie L. Fusco et al. PLoS Pathogens
- Ebola virus vaccines: an overview of current approaches
- (2014) Andrea Marzi et al. Expert Review of Vaccines
- High level transient production of recombinant antibodies and antibody fusion proteins in HEK293 cells
- (2013) Volker Jäger et al. BMC BIOTECHNOLOGY
- Inhibition of Marburg Virus Budding by Nonneutralizing Antibodies to the Envelope Glycoprotein
- (2012) M. Kajihara et al. JOURNAL OF VIROLOGY
- Antibodies for biodefense
- (2012) Jeffrey W. Froude et al. mAbs
- Isolation and Characterisation of a Human-Like Antibody Fragment (scFv) That Inactivates VEEV In Vitro and In Vivo
- (2012) Torsten Rülker et al. PLoS One
- Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease
- (2012) J. M. Dye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ebola and Marburg Hemorrhagic Fevers: Neglected Tropical Diseases?
- (2012) Adam MacNeil et al. PLoS Neglected Tropical Diseases
- Filovirius vaccines
- (2011) Steven B. Bradfute et al. Human vaccines & immunotherapeutics
- A human scFv antibody generation pipeline for proteome research
- (2010) Michael Hust et al. JOURNAL OF BIOTECHNOLOGY
- Non-human primate immune libraries combined with germline humanization
- (2010) Thibaut Pelat et al. mAbs
- Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity
- (2009) Thibaut Pelat et al. BMC BIOTECHNOLOGY
- Development and Characterization of a Mouse Model for Marburg Hemorrhagic Fever
- (2009) K. L. Warfield et al. JOURNAL OF VIROLOGY
- Identification of a Putative Crf Splice Variant and Generation of Recombinant Antibodies for the Specific Detection of Aspergillus fumigatus
- (2009) Mark Schütte et al. PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started